Literature DB >> 11249903

Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow.

N Kurtoglu1, A Akcay, I Dindar.   

Abstract

We evaluated the efficiacy of oral diypridamole therapy for the normalization of angiographically determined slow coronary artery flow. Diypridamole, which has dilatator properties on coronary microvessels, proved to be an effective treatment in most patients with slow coronary artery flow.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11249903     DOI： 10.1016/s0002-9149(00)01503-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  The coronary slow flow phenomenon: characteristics, mechanisms and implications.

Authors:  Xiao Wang; Shao-Ping Nie
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

2.  Effects of slow coronary artery flow on QT interval duration and dispersion.

Authors:  Ramazan Atak; Hasan Turhan; Alpay T Sezgin; Ozkan Yetkin; Kubilay Senen; Mehmet Ileri; Onur Sahin; Orhan Karabal; Ertan Yetkin; Emine Kutuk; Deniz Demirkan
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

3.  Effects of nebivolol on endothelial function and exercise parameters in patients with slow coronary flow.

Authors:  Selma Tiryakioglu; Osman Tiryakioglu; Hasan Ari; Mehmet C Basel; Tahsin Bozat
Journal:  Clin Med Cardiol       Date:  2009-11-03

4.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

5.  The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow.

Authors:  Hasan Pekdemir; Dilek Cicek; Ahmet Camsari; M Necdet Akkus; V Gokhan Cin; Oben Doven; H Tuncay Parmaksiz; M Tuna Katircibasi; I Turkay Ozcan
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

6.  Increased serum resistin levels in patients with coronary slow-flow phenomenon.

Authors:  A Canga; M Cetin; S A Kocaman; M E Durakoğlugil; A Kırbaş; T Erdoğan; A Temiz; A Yılmaz; Y Ciçek
Journal:  Herz       Date:  2013-02-13       Impact factor: 1.443

7.  Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature.

Authors:  Muhammad A Chaudhry; Marcus Smith; Elias B Hanna; Ralph Lazzara
Journal:  Cardiol Res Pract       Date:  2012-05-08       Impact factor: 1.866

8.  Slow Coronary Flow is Related to Increased Carotid Intima-Media Thickness but Not Pulse Wave Velocity.

Authors:  Bum Sung Kim; Hyun-Joong Kim; Seong Woo Han; Sung Hea Kim; Soon Yong Suh; Sang Man Chung; Kyu Hyung Ryu
Journal:  Korean Circ J       Date:  2011-11-29       Impact factor: 3.243

9.  Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow.

Authors:  Emine Gazi; Ahmet Temiz; Burak Altun; Ahmet Barutcu; Fatma Silan; Yucel Colkesen; Ozturk Ozdemir
Journal:  Cardiovasc J Afr       Date:  2014-01-17       Impact factor: 1.167

10.  Evaluation of serum prolidase activity in patients with slow coronary flow.

Authors:  Arif Suner; Abdullah Nurdag; Mustafa Polat; Hakan Kaya; Sedat Koroglu; Gurkan Acar; Hatice Sezen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.